Fran White and Joanne Lebrun will continue to serve in executive management roles.

A truly end-to-end regulatory compliant clinical supply chain solution.

Cost analysis findings include savings of over $1 million per trial.

Patti Glaza of Invest Detroit joins Ripple Science Board of Directors

MedEvoke, an industry leader in Global Alignment, amplifies its creative team with a pharma MM&M Top 100 Agency award-winning leader, and adds weight to its growing clinical content team by adding a doctoral specialist in gene therapy that will help increase awareness in this breakthrough area of research.

The Sternfels Prize winner was selected for her novel hypothesis titled 'Experimental Medicine Approach to Optimize Diabetes Treatments'

Annual Prize of $35,000 Awarded to Diabetes Research Proposal

One of the greatest challenges to achieving clean data in clinical trials is controlling the consistency of terminology.

Focusing on Pharmaceutical, CROs, consultancy companies and other 3rd parties looking to improve their clinical trial efficiency.

MedEvoke, an industry leader in Global Alignment, announces two new hires who will join the ten new hires brought onboard in January, to service both the core Medical Affairs staff, as well as the growing Clinical Trials division.

MedEvoke, an industry leader in Global Alignment, announces a new Clinical Trials division to add to its growing cache of offerings designed to serve its global client list. The Clinical Trials division will help clients align their protocols with one single scientific voice and targeted enrollment strategy for optimal trial management and outcomes.

Application of Real-World Patient Data Radically Enhances Volunteer Commitment

5 lessons to master clinical data aggregation, transformation, cleaning and analytics to reduce cost, risk and time

Companies to collaborate to accelerate the use of standards in the planning stage of clinical trials

The science looks promising and vital funding has been secured to take the compound to the clinical stage. What is the best strategy for operationalizing an oncology study in a clinical setting to meet business objectives?

The push to implement risk-based monitoring is continuing across the industry, yet many sponsors are struggling to find the right methods and technology to implement risk-based monitoring, resulting in a time-consuming and expensive effort.

Relationship Seeks to Re-Establish Rochester as Pediatric Research Leader

Much of the discussion around patient-centricity today is centered around trial design, which is important and commendable work. Unfortunately, focusing primarily on design overlooks how to instill patient-centric concepts and create a friendly environment in the study once the protocol is finalized.